Search Generic Medicine

Medicine Index

Search by generic name

Tag: Melanoma

Generic Vemurafenib

Vemurafenib is an orally bioavailable, ATP-competitive, small-molecule inhibitor of BRAF(V600E) kinase with potential antineoplastic activity. Vemurafenib selectively binds to the ATP-binding site of BRAF(V600E) kinase and inhibits its activity, which may result in an inhibition of an over-activated MAPK signaling pathway downstream in BRAF(V600E) kinase-expressing tumor cells and a reduction . . . Read more

Generic Cobimetinib

Cobimetinib is an orally bioavailable small-molecule inhibitor of mitogen-activated protein kinase kinase 1 (MAP2K1 or MEK1), with potential antineoplastic activity. Cobimetinib specifically binds to and inhibits the catalytic activity of MEK1, resulting in inhibition of extracellular signal-related kinase 2 (ERK2) phosphorylation and activation and decreased tumor cell proliferation. Preclinical studies . . . Read more

Generic Trametinib

Trametinib is an orally bioavailable inhibitor of mitogen-activated protein kinase kinase (MAP2K; MAPK/ERK kinase; MEK) 1 and 2, with potential antineoplastic activity. Trametinib can be used in combination with Dabrafenib to treat people with a type of skin cancer called melanoma: That has spread to other parts of the body . . . Read more

Generic Dabrafenib

Dabrafenib is a selective inhibitor of mutated forms of BRAF kinase and is used alone or in combination with trametinib  to treat certain types of cancer in people who have a “BRAF” gene mutation. dabrafenib is for use in treating: for the treatment of patients with unresectable or metastatic melanoma . . . Read more